GENE ONLINE|News &
Opinion
Blog

Liver Disease
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Breakthrough Stem Cell Treatment Shows Promise in Reversing Liver Disease
2023-12-08
Verve and Vertex Agree to Co-Develop In Vivo Gene Editing Program for Liver Disease
2022-07-21
Takeda To Develop Rare Liver Disease Treatments with Genevant in $303M Pact
2021-08-24
Albireo Gets Back-to-Back Approvals for Rare Liver Disease Drug
2021-07-26
R&D
NASH Drug Candidate, ASC42 Receives Fast Track Designation
2020-12-18
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17
LATEST
Google DeepMind Open-Sources AlphaFold 3: A Game-Changer for Drug Discovery and Biotech
2024-11-12
Hiroaki Ueno: Leading Japan’s Pharma Revolution with Innovation and Global Strategy
2024-11-12
Japan’s Bio-Economy Push: A Future Driven by Innovation and Global Collaboration
2024-11-12
Opening the Door to ‘Designer Babies’? South Africa’s Genome Editing Guidelines Spark Global Debate
2024-11-08
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
2024-11-08
United Imaging Receives First Approval in Canada
2024-11-07
BioNTech’s Bold Move: Rwanda’s New mRNA Vaccine Factory Set to Boost African Healthcare
2024-11-06
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top